Methylation-mediated gene silencing of suppressor of cytokine signaling-1 (SOCS-1) gene in esophageal squamous cell carcinoma patients of Kashmir valley

Journal of Receptors and Signal Transduction

Volumn 31, Issue 2, 2011, Pages 147-156

  Hussain, Showket ^a   Singh, Neha ^b   Salam, Irfana ^c   Bandil, Kapil ^a   Yuvaraj, M ^a   Akbar Bhat, Mohammad ^c   Muzaffar Mir, Mohammad ^b   Siddiqi, Mushtaq A ^c   Sobti, Ranbir C ^b   Bharadwaj, Mausumi ^a   Das, Bhudev C ^d  

^a Institute of Cytology and Preventive Oncology ICMR   (India)

^b PANJAB UNIVERSITY   (India)

^c SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

^d UNIVERSITY OF DELHI   (India)

Author keywords

ESCC; promoter methylation; SOCS 1

Indexed keywords

STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ARTICLE; CANCER STAGING; DISEASE SEVERITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS BIOPSY; FEMALE; GENE SILENCING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METHYLATION; PREVALENCE; PROMOTER REGION; PROTEIN EXPRESSION; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; INDIA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

HUMAN PAPILLOMAVIRUS;

EID: 79952591142     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2011.553836     Document Type: Article

References (62)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55, 74-108.
2. Khuroo MS, Zargar SA, Mahajan R, Banday MA. High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut 1992, 33, 11-15.
3. Katiyar S, Hedau S, Jain N, Kar P, Khuroo MS, Mohanta J, Kumar S, Gopalkrishna V, Kumar N, Das BC. p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett 2005, 218, 69-79. (Pubitemid 40082703)
4. Van Duuren BL. Tobacco carcinogenesis. Cancer Res 1968, 28, 2357-2362.
5. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006, 24 (Suppl 3), S3/S11-S25. (Pubitemid 44404053)
6. Katiyar S, Hedau S, Jain N, Kar P, Khuroo MS, Mohanta J, Kumar S, Gopalkrishna V, Kumar N, Das BC. p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett 2005, 218, 69-79. (Pubitemid 40082703)
7. Syrjänen KJ. HPV infections and oesophageal cancer. J Clin Pathol 2002, 55, 721-728. (Pubitemid 35231898)
8. Hussain S, Bharti AC, Salam I, Bhat MA, Mir MM, Hedau S, Siddiqi MA, Basir SF, Das BC. Transcription factor AP-1 in esophageal squamous cell carcinoma: alterations in activity and expression during human papillomavirus infection. BMC Cancer 2009, 9, 329.
9. Kamio M, Yoshida T, Ogata H, Douchi T, Nagata Y, Inoue M, Hasegawa M, Yonemitsu Y, Yoshimura A. SOCS1 [corrected] inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein. Oncogene 2004, 23, 3107-3115. (Pubitemid 38648201)
10. Spandidos DA. Oncogenes and tumor suppressor genes as paradigms in oncogenesis. J BUON 2007, 12 (Suppl 1), S9-S12. (Pubitemid 350200856)
11. Bringold F, Serrano M. Tumor suppressors and oncogenes in cellular senescence. Exp Gerontol 2000, 35, 317-329. (Pubitemid 30314689)
12. Esteller M, Herman JG. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 2002, 196, 1-7.
13. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 2001, 10, 687-692. (Pubitemid 32331576)
14. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000, 16, 168-174. (Pubitemid 30169152)
15. Cohen Y, Merhavi-Shoham E, Avraham RB, Frenkel S, Pe'er J, Goldenberg-Cohen N. Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma. Exp Eye Res 2008, 86, 201-206.
16. Smith E, De Young NJ, Tian ZQ, Caruso M, Ruszkiewicz AR, Liu JF, Jamieson GG, Drew PA. Methylation of TIMP3 in esophagealsquamous cell carcinoma. World J Gastroenterol 2008, 14, 203-210. (Pubitemid 351314300)
17. Tanaka K, Imoto I, Inoue J, Kozaki K, Tsuda H, Shimada Y, Aiko S, Yoshizumi Y, Iwai T, Kawano T, Inazawa J. Frequent methylationassociated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma. Oncogene 2007, 26, 6456-6468. (Pubitemid 47494215)
18. Guo XQ, Wang SJ, Zhang LW, Wang XL, Zhang JH, Guo W. DNA methylation and loss of protein expression in esophageal squamous cell carcinogenesis of high-risk area. J Exp Clin Cancer Res 2007, 26, 587-594. (Pubitemid 351157879)
19. Yamashita K, Upadhyay S, Osada M, Hoque MO, Xiao Y, Mori M, Sato F, Meltzer SJ, Sidransky D. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2002, 2, 485-495. (Pubitemid 41043953)
20. Sobti RC, Singh N, Hussain S, Suri V, Bharadwaj M, Das BC. Deregulation of STAT-5 isoforms in the development of HPVmediated cervical carcinogenesis. J Recept Signal Transduct Res 2010, 30, 178-188.
21. Sobti RC, Singh N, Hussain S, Suri V, Bharti AC, Das BC. Overexpression of STAT3 in HPV-mediated cervical cancer in a North Indian population. Mol Cell Biochem 2009, 330, 193-199.
22. Lin TS, Mahajan S, Frank DA. STAT signaling in the pathogenesis and treatment of leukemias. Oncogene 2000, 19, 2496-2504. (Pubitemid 30339205)
23. Yu H, Jove R. The STATs of cancer-new molecular targets come of age. Nat Rev Cancer 2004, 4, 97-105. (Pubitemid 38198738)
24. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997, 387, 921-924. (Pubitemid 27289595)
25. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ. A family of cytokine-inducible inhibitors of signalling. Nature 1997, 387, 917-921. (Pubitemid 27289594)
26. Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE, Harris CC, Herman JG. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 2001, 28, 29-35. (Pubitemid 32405812)
27. Galm O, Yoshikawa H, Esteller M, Osieka R, Herman JG. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood 2003, 101, 2784-2788. (Pubitemid 36857644)
28. Fukushima N, Sato N, Sahin F, Su GH, Hruban RH, Goggins M. Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms. Br J Cancer 2003, 89, 338-343. (Pubitemid 36980626)
29. Huang FJ, Steeg PS, Price JE, Chiu WT, Chou PC, Xie K, Sawaya R, Huang S. Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis. Cancer Res 2008, 68, 9634-9642.
30. Rottapel R, Ilangumaran S, Neale C, La Rose J, Ho JM, Nguyen MH, Barber D, Dubreuil P, de Sepulveda P. The tumor suppressor activity of SOCS-1. Oncogene 2002, 21, 4351-4362. (Pubitemid 34774838)
31. Elliott J, Hookham MB, Johnston JA. The suppressors of cytokine signalling E3 ligases behave as tumour suppressors. Biochem Soc Trans 2008, 36, 464-468. (Pubitemid 351839356)
32. Das BC, Sharma JK, Gopalakrishna V, Luthra UK. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J Gen Virol 1992, 73 (Pt 9), 2327-2336.
33. Kailash U, Soundararajan CC, Lakshmy R, Arora R, Vivekanandhan S, Das BC. Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer. Br J Cancer 2006, 95, 1250-1257. (Pubitemid 44658491)
34. Kumar R, Mende P, Wacker CD, Spiegelhalder B, Preussmann R, Siddiqi M. Caffeine-derived N-nitroso compounds-I: nitrosatable precursors from caffeine and their potential relevance in the etiology of oesophageal and gastric cancers in Kashmir, India. Carcinogenesis 1992, 13, 2179-2182.
35. Fukuoka T, Hibi K, Nakao A. Aberrant methylation is frequently observed in advanced esophageal squamous cell carcinoma. Anticancer Res 2006, 26, 3333-3335. (Pubitemid 44701505)
36. Xing EP, Nie Y, Song Y, Yang GY, Cai YC, Wang LD, Yang CS. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res 1999, 5, 2704-2713. (Pubitemid 29493943)
37. Anupam K, Tusharkant C, Gupta SD, Ranju R. Loss of disabled-2 expression is an early event in esophageal squamous tumorigenesis. World J Gastroenterol 2006, 12, 6041-6045. (Pubitemid 44608486)
38. Kim YT, Park JY, Jeon YK, Park SJ, Song JY, Kang CH, Sung SW, Kim JH. Aberrant promoter CpG island hypermethylation of the adenomatosis polyposis coli gene can serve as a good prognostic factor by affecting lymph node metastasis in squamous cell carcinoma of the esophagus. Dis Esophagus 2009, 22, 143-150.
39. Lam KY, Tsao SW, Zhang D, Law S, He D, Ma L, Wong J. Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: a prospective clinico-pathological study and survival analysis of 70 patients. Int J Cancer 1997, 74, 212-219. (Pubitemid 27234513)
40. Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 2007, 16 (Spec No 1), R50-R59. (Pubitemid 47241842)
41. Zare M, Jazii FR, Alivand MR, Nasseri NK, Malekzadeh R, Yazdanbod M. Qualitative analysis of adenomatous polyposis coli promoter: hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker. BMC Cancer 2009, 9, 24.
42. Salam I, Hussain S, Mir MM, Dar NA, Abdullah S, Siddiqi MA, Lone RA, Zargar SA, Sharma S, Hedau S, Basir SF, Bharti AC, Das BC. Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: a high-risk area. Mol Cell Biochem 2009, 332, 51-58.
43. Tischoff I, Hengge UR, Vieth M, Ell C, Stolte M, Weber A, Schmidt WE, Tannapfel A. Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett's adenocarcinoma. Gut 2007, 56, 1047-1053. (Pubitemid 47123231)
44. Hibi K, Kodera Y, Ito K, Akiyama S, Nakao A. Aberrant methylation of HLTF, SOCS-1, and CDH13 genes is shown in colorectal cancers without lymph node metastasis. Dis Colon Rectum 2005, 48, 1282-1286. (Pubitemid 40897877)
45. Fujitake S, Hibi K, Okochi O, Kodera Y, Ito K, Akiyama S, Nakao A. Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients. J Gastroenterol 2004, 39, 120-124. (Pubitemid 38325187)
46. Endo T, Toyota M, Imai K. Silencing of negative regulator of JAK/STAT in colorectal cancer. J Gastroenterol 2004, 39, 200-201. (Pubitemid 38325202)
47. Oshimo Y, Kuraoka K, Nakayama H, Kitadai Y, Yoshida K, Chayama K, Yasui W. Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma. Int J Cancer 2004, 112, 1003-1009. (Pubitemid 39507006)
48. To KF, Chan MW, Leung WK, Ng EK, Yu J, Bai AH, Lo AW, Chu SH, Tong JH, Lo KW, Sung JJ, Chan FK. Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line. Br J Cancer 2004, 91, 1335-1341. (Pubitemid 39424795)
49. Komazaki T, Nagai H, Emi M, Terada Y, Yabe A, Jin E, Kawanami O, Konishi N, Moriyama Y, Naka T, Kishimoto T. Hypermethylationassociated inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human pancreatic cancers. Jpn J Clin Oncol 2004, 34, 191-194. (Pubitemid 43102896)
50. Jin Z, Hamilton JP, Yang J, Mori Y, Olaru A, Sato F, Ito T, Kan T, Cheng Y, Paun B, David S, Beer DG, Agarwal R, Abraham JM, Meltzer SJ. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression. Cancer Epidemiol Biomarkers Prev 2008, 17, 111-117. (Pubitemid 351196280)
51. Flatley JE, McNeir K, Balasubramani L, Tidy J, Stuart EL, Young TA, Powers HJ. Folate status and aberrant DNA methylation areassociated with HPV infection and cervical pathogenesis. Cancer Epidemiol Biomarkers Prev 2009, 18, 2782-2789.
52. Tanemura A, Terando AM, Sim MS, van Hoesel AQ, de Maat MF, Morton DL, Hoon DS. CpG island methylator phenotype predicts progression of malignant melanoma. Clin Cancer Res 2009, 15, 1801-1807.
53. Fakhry C, Gillison ML. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 2006, 24, 2606-2611. (Pubitemid 46622080)
54. Mishra A, Bharti AC, Varghese P, Saluja D, Das BC. Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection. Int J Cancer 2006, 119, 2840-2850. (Pubitemid 44846236)
55. Datta NR, Kumar P, Singh S, Gupta D, Srivastava A, Dhole TN. Does pretreatment human papillomavirus (HPV) titers predict radiation response and survival outcomes in cancer cervix?-a pilot study. Gynecol Oncol 2006, 103, 100-105. (Pubitemid 44374675)
56. Das BC, Hussain S, Nasare V, Bharadwaj M. Prospects and prejudices of human papillomavirus vaccines in India. Vaccine 2008, 26, 2669-2679.
57. Thierry F. Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma. Virology 2009, 384, 375-379.
58. Travagli J, Letourneur M, Bertoglio J, Pierre J. STAT6 and Ets-1 form a stable complex that modulates Socs-1 expression by interleukin-4 in keratinocytes. J Biol Chem 2004, 279, 35183-35192. (Pubitemid 39100514)
59. Liu P, Kimmoun E, Legrand A, Sauvanet A, Degott C, Lardeux B, Bernuau D. Activation of NF-kappa B, AP-1 and STAT transcription factors is a frequent and early event in human hepatocellular carcinomas. J Hepatol 2002, 37, 63-71. (Pubitemid 34713056)
60. Yang B, Guo M, Herman JG, Clark DP. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 2003, 163, 1101-1107. (Pubitemid 37040145)
61. Miyoshi H, Fujie H, Shintani Y, Tsutsumi T, Shinzawa S, Makuuchi M, Kokudo N, Matsuura Y, Suzuki T, Miyamura T, Moriya K, Koike K. Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression. J Hepatol 2005, 43, 757-763. (Pubitemid 41414500)
62. Siddiqi M, Preussmann R. Esophageal cancer in Kashmir-an assessment. J Cancer Res Clin Oncol 1989, 115, 111-117.